Exaggerations and Misrepresentations Have No Place in Science Policy Debates
By Jeremy Gruber,
Council for Responsible Genetics
| 02. 15. 2013
Yesterday
Intelligence Squared held a debate (
watch it in its entirety here) on whether we should prohibit genetically engineered babies. Arguing for the motion were CRG Board Chair Professor Sheldon Krimsky and Robert Winston, professor at Imperial College London. Arguing against the motion was Nita Farahany, professor at Duke University and a member of the Presidential Commission for the Study of Bioethical Issues and Lee Silver, professor at Princeton University.
The debate quickly turned to focus on mitochondrial disease, a group of disorders caused by dysfunctional mitochondria, the organelles that generate energy for the cell and a new technique for treating such diseases that would, for the first time, allow the creation of babies whose genes have been intentionally altered by replacing the mitochondrial DNA. In focusing on this, and exclusively this element of genetic engineering, opponents of a ban managed to avoid any debate over genetic engineering purely for enhancement purposes. Indeed, Professor Silver seemed to distance himself from the more controversial opinions he espoused in his book,
Remaking Eden: How Genetic Engineering and Cloning Will Transform...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Alexandra Marquez, NBC News | 03.13.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a...